| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSB2100008 | 重组抗VEGF人源化单克隆抗体注射液 | Injection | Biological Products(1) | Supplementary Application | 2021-01-29 | 上海复宏汉霖生物技术股份有限公司；上海复宏汉霖生物制药有限公司 | Shanghai Henlius Biopharmaceutical Co Ltd;Shanghai Henlius Biotech Co Ltd | In Review | 2021-01-28 | view |